Lukas Dostalek

6PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer geneticsEpidemiological methodsMolecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Dec 23, 2023
Risk Factors for the Anal and Oral Human Papillomavirus (HPV) Infections among Women with Severe Cervical Lesions: A Prospective Case-Control Study.

Monika Nipčová Džundová, Borek Sehnal, Michal Zikán

|Dec 06, 2023
HPV testing as an effective triage strategy in the follow-up after fertility-sparing treatment for glandular lesions of the uterine cervix.

Lukas Dostalek, Pavel Freitag, Miroslava Slovackova

|Aug 24, 2022
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets.

Chiara Herzog, Fátima Marín, Allison Jones

|Apr 03, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

Maggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface

|Mar 19, 2020
Is it possible to abandon sentinel lymph node biopsy in breast cancer patients with negative axillary ultrasound in the post-Z0011 era? A retrospective analysis.

Lukas Dostalek, Stefan Lednicky, Petra Saskova

Pageof 1

Frequent Collaborators

2 joint publications

Jana de Boniface

2 joint publications

Oreste Gentilini

2 joint publications

Eduard-Alexandru Bonci

2 joint publications

Laura Niinikoski